{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T03:05:12Z","timestamp":1779419112018,"version":"3.53.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although clinical malaria occurs far less frequently in newborns and young infants aged \u2009&lt;6\u00a0months than in older children, its importance and public health relevance should not be ignored. This population is often perceived to have protection against malaria, and making a diagnosis of malaria in this age group can be challenging, as the symptoms generally overlap with those of many other common conditions in infancy, possibly leading to misdiagnosis or treatment delay. This narrative review synthesises current evidence, explores existing treatment recommendations, and highlights practice gaps in malaria management in children aged &lt;6\u00a0months (or weighing &lt;5\u00a0kg).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was conducted using PubMed, EMBASE, and Google Scholar and supplemented with World Health Organization and region-specific malaria treatment guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Data on malaria prevalence in young infants are highly variable and heterogeneous, reflecting differences in the methodology used, diagnostic criteria and treatment approaches. Evidence regarding the safety and efficacy of available antimalarial therapies in this population is limited, and until recently, no antimalarial agents were licensed for neonates or infants weighing \u2009&lt;4.5\u00a0kg. Consequently, current recommendations may not adequately address the needs of this vulnerable group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Given the variability in the guidelines across different countries, there is an urgent need to make specific policy and practice amendments that can enhance understanding, bridge existing knowledge gaps and harmonise treatment approaches for at-risk populations worldwide.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41182-026-00935-5","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:14:45Z","timestamp":1777040085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Malaria in children aged &lt;6\u00a0months: a narrative review of current evidence, recommendations and practice gaps"],"prefix":"10.1186","volume":"54","author":[{"given":"J\u00e9ssica","family":"Dalsuco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quique","family":"Bassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Winnips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Boulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nekoye","family":"Otsyula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"935_CR1","unstructured":"World Health Organization. World malaria report 2025. Geneva: World Health Organization; 2025. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2025. Accessed 09 Jan 2026."},{"key":"935_CR2","unstructured":"World Health Organization. Malaria factsheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malaria. Accessed 04 Mar 2025."},{"key":"935_CR3","unstructured":"World Health Organization guidelines for malaria. 13 August 2025. Geneva: World Health Organization; 2025. https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria. Accessed 25 Sep 2025."},{"issue":"1","key":"935_CR4","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/S2214-109X(22)00431-4","volume":"11","author":"V Reddy","year":"2023","unstructured":"Reddy V, Weiss DJ, Rozier J, ter Kuile FO, Dellicour S. Global estimates of the number of pregnancies at risk of malaria from 2007 to 2020: a demographic study. Lancet Glob Health. 2023;11(1):e40\u20137.","journal-title":"Lancet Glob Health"},{"key":"935_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.50","author":"MA Philips","year":"2017","unstructured":"Philips MA, Burrows JN, Manyando C, van Huijsduijnen RH, Van Voorhis WC, Wells TNC. Malaria. Nat Rev Dis Primers. 2017. https:\/\/doi.org\/10.1038\/nrdp.2017.50.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"935_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1017\/S0031182015001626","volume":"143","author":"KR Dobbs","year":"2016","unstructured":"Dobbs KR, Dent AE. Plasmodium malaria and antimalarial antibodies in the first year of life. Parasitology. 2016;143(2):129\u201338.","journal-title":"Parasitology"},{"issue":"2","key":"935_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1365-3024.2001.00364.x","volume":"23","author":"EM Riley","year":"2001","unstructured":"Riley EM, Wagner GE, Akanmori BD, Koram KA. Do maternally acquired antibodies protect infants from malaria infection? Parasite Immunol. 2001;23(2):51\u20139.","journal-title":"Parasite Immunol"},{"issue":"9","key":"935_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185303","volume":"12","author":"KA Kusi","year":"2017","unstructured":"Kusi KA, Manu EA, Gwira TM, Kyei-Baafour E, Dickson EK, Amponsah JA, et al. Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana. PLoS ONE. 2017;12(9):e0185303.","journal-title":"PLoS ONE"},{"key":"935_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2657-6","author":"A Reynaldi","year":"2019","unstructured":"Reynaldi A, Dent AE, Schlub TE, Ogolla S, Rochford R, Davenport MP. Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants. Malar J. 2019. https:\/\/doi.org\/10.1186\/s12936-019-2657-6.","journal-title":"Malar J"},{"issue":"2","key":"935_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","volume":"7","author":"M Desai","year":"2007","unstructured":"Desai M, ter Kuile F, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7(2):93\u2013104.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"935_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1473-3099(07)70022-1","volume":"7","author":"S Rogerson","year":"2007","unstructured":"Rogerson S, Hviid L, Duffy P, Leke R, Taylor D. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis. 2007;7(2):105\u201317.","journal-title":"Lancet Infect Dis"},{"key":"935_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/CMR.00025-08","volume":"22","author":"DL Doolan","year":"2009","unstructured":"Doolan DL, Doba\u00f1o C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22:13\u201336.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"935_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jinf.2021.02.024","volume":"82","author":"S Alonso","year":"2021","unstructured":"Alonso S, Vidal M, Ruiz-Olalla G, Gonz\u00e1lez R, Jairoce C, Manaca MN, et al. HIV infection and placental malaria reduce maternal transfer of multiple antimalarial antibodies in Mozambican women. J Infect. 2021;82(4):45\u201357.","journal-title":"J Infect"},{"key":"935_CR14","unstructured":"European Medicines Agency. ICH E11(R1) guideline on clinical investigation of medicinal products in the pediatric population (EMA\/CPMP\/\/ICH\/2711\/99). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e11r1-guideline-clinical-investigation-medicinal-products-pediatric-population-revision-1-addendum_en.pdf. Accessed 13 Jun 2025."},{"key":"935_CR15","unstructured":"European Medicines Agency. ICH Topic E11: Clinical Investigation of medicinal products in the paediatric population (CPMP\/ICH\/2711\/99). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/e-11-clinical-investigation-medicinal-products-paediatric-population-step-5_en.pdf. Accessed 13 Jun 2025."},{"key":"935_CR16","unstructured":"World Health Organization. Weight-for-age charts. https:\/\/www.who.int\/tools\/child-growth-standards\/standards\/weight-for-age. Accessed 21 Jun 2025."},{"key":"935_CR17","first-page":"395","volume":"163","author":"PR Fischer","year":"1995","unstructured":"Fischer PR, Nyirjesy P, Toko RM. Congenital malaria in twins. West J Med. 1995;163:395\u20136.","journal-title":"West J Med"},{"key":"935_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-400","author":"U D\u2019Alessandro","year":"2012","unstructured":"D\u2019Alessandro U, Ubben D, Hamed K, Ceesay SJ, Okebe J, Taal M, et al. Malaria in infants aged less than six months\u2014is it an area of unmet medical need? Malar J. 2012. https:\/\/doi.org\/10.1186\/1475-2875-11-400.","journal-title":"Malar J"},{"key":"935_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/clinids\/16.1.127","volume":"16","author":"P Nyirjesy","year":"1993","unstructured":"Nyirjesy P, Kavasya T, Axelrod P, Fischer PR. Malaria during pregnancy: neonatal morbidity and mortality and the efficacy of chloroquine chemoprophylaxis. Clin Infect Dis. 1993;16:127\u201332.","journal-title":"Clin Infect Dis"},{"key":"935_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2327-0","author":"P Olupot-Olupot","year":"2018","unstructured":"Olupot-Olupot P, Eregu EIE, Naizuli K, Ikiror J, Acom L, Burgoine K. Neonatal and congenital malaria: a case series in malaria endemic eastern Uganda. Malar J. 2018. https:\/\/doi.org\/10.1186\/s12936-018-2327-0.","journal-title":"Malar J"},{"key":"935_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03373-8","author":"C Danwang","year":"2020","unstructured":"Danwang C, Bigna JJ, Nzalie RNT, Robert A. Epidemiology of clinical congenital and neonatal malaria in endemic settings: a systematic review and meta-analysis. Malar J. 2020. https:\/\/doi.org\/10.1186\/s12936-020-03373-8.","journal-title":"Malar J"},{"issue":"15","key":"935_CR22","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1080\/14656566.2022.2130687","volume":"23","author":"LC Kalkman","year":"2022","unstructured":"Kalkman LC, Hanscheid T, Krishna S, Kremsner PG, Grobusch MP. Antimalarial treatment in infants. Expert Opin Pharmacother. 2022;23(15):1711\u201326.","journal-title":"Expert Opin Pharmacother"},{"key":"935_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/46.2.92","author":"OO Kassim","year":"2000","unstructured":"Kassim OO, Ako-Anai KA, Torimiro SE, Hollowell GP, Okoye VC, Martin SK. Inhibitory factors in breastmilk, maternal and infant sera against in vitro growth of Plasmodium falciparum malaria parasite. J Trop Pediatr. 2000. https:\/\/doi.org\/10.1093\/tropej\/46.2.92.","journal-title":"J Trop Pediatr"},{"key":"935_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12806","author":"ME Feeney","year":"2020","unstructured":"Feeney ME. The immune response to malaria in utero. Immunol Rev. 2020. https:\/\/doi.org\/10.1111\/imr.12806.","journal-title":"Immunol Rev"},{"key":"935_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014798","author":"C Amaratunga","year":"2011","unstructured":"Amaratunga C, Lopera-Mesa TM, Brittain NJ, Cholera R, Arie T, Fujioka H, et al. A role for fetal hemoglobin and maternal immune IgG in infant resistance to Plasmodium falciparum malaria. PLoS ONE. 2011. https:\/\/doi.org\/10.1371\/journal.pone.0014798.","journal-title":"PLoS ONE"},{"issue":"14","key":"935_CR26","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1182\/bloodadvances.2019000399","volume":"3","author":"NM Archer","year":"2019","unstructured":"Archer NM, Petersen N, Duraisingh MT. Fetal hemoglobin does not inhibit Plasmodium falciparum growth. Blood Adv. 2019;3(14):2149\u201352.","journal-title":"Blood Adv"},{"key":"935_CR27","doi-asserted-by":"publisher","DOI":"10.1086\/379373","author":"GA Kicska","year":"2003","unstructured":"Kicska GA, Ting LM, Schramm VL, Kim K. Effect of dietary p-aminobenzoic acid on murine Plasmodium yoelii infection. J Infect Dis. 2003. https:\/\/doi.org\/10.1086\/379373.","journal-title":"J Infect Dis"},{"issue":"6","key":"935_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.4269\/ajtmh.2001.65.822","volume":"65","author":"BM Afolabi","year":"2001","unstructured":"Afolabi BM, Salako LA, Mafe AG, Ovwigho UB, Rabiu KA, Sanyaolu NO, et al. Malaria in the first 6 months of life in urban African infants with anemia. Am J Trop Med Hyg. 2001;65(6):822\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"935_CR29","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.4103\/jfmpc.jfmpc_2332_22","volume":"12","author":"K Mohan","year":"2023","unstructured":"Mohan K, Omar BJ, Chacham S. Malaria in newborn: a missed entity for primary care physician. J Family Med Prim Care. 2023;12(8):1511\u20135.","journal-title":"J Family Med Prim Care"},{"issue":"7","key":"935_CR30","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3201\/eid2107.142036","volume":"21","author":"SJ Ceesay","year":"2015","unstructured":"Ceesay SJ, Koivogui L, Nahum A, Taal MA, Okebe J, Affara M, et al. Malaria prevalence among young infants in different transmission settings, Africa. Emerg Infect Dis. 2015;21(7):1114\u201321.","journal-title":"Emerg Infect Dis"},{"key":"935_CR31","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ejogrb.2020.06.025","volume":"252","author":"JA Bilal","year":"2020","unstructured":"Bilal JA, Malik EE, Al-Nafeesah A, Adam I. Global prevalence of congenital malaria: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;252:534\u201342.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"935_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/archdischild-2023-325906","volume":"109","author":"YR Adeniji","year":"2024","unstructured":"Adeniji YR, Jalo I, Okonkwo I, Poksireni MR, Manga M, Wariri O, et al. Diagnostic value of rapid test for malaria among febrile neonates in a tertiary hospital in North-East Nigeria: a prospective cross-sectional study. Arch Dis Child. 2024;109:11\u20135.","journal-title":"Arch Dis Child"},{"issue":"1","key":"935_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2315-4","volume":"17","author":"HM Natama","year":"2018","unstructured":"Natama HM, Rovira-Vallbona E, Som\u00e9 MA, Zango SH, Sorgho H, Guetens P, et al. Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study. Malar J. 2018;17(1):163.","journal-title":"Malar J"},{"issue":"1","key":"935_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03394-3","volume":"19","author":"A Nhama","year":"2020","unstructured":"Nhama A, Varo R, Bassat Q. Highlighting the burden of malarial infection and disease in the neonatal period: making sense of different concepts. Malar J. 2020;19(1):311. https:\/\/doi.org\/10.1186\/s12936-020-03394-3.","journal-title":"Malar J"},{"issue":"1","key":"935_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-025-05257-1","volume":"24","author":"E Kokori","year":"2025","unstructured":"Kokori E, Olatunji G, Ukoaka BM, Abraham IC, Komolafe R, Ajekiigbe VO, et al. Prevalence, characteristics, and treatment outcome of congenital malaria in Nigeria: a systematic review. Malar J. 2025;24(1):24.","journal-title":"Malar J"},{"issue":"7","key":"935_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255028","volume":"16","author":"JA Cardona-Arias","year":"2021","unstructured":"Cardona-Arias JA, Carmona-Fonseca J. Meta-analysis of the prevalence of malaria associated with pregnancy in Colombia 2000-2020. PLoS ONE. 2021;16(7):e0255028.","journal-title":"PLoS ONE"},{"key":"935_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-36","author":"C Guinovart","year":"2008","unstructured":"Guinovart C, Bassat Q, Siga\u00faque B, Aide P, Sacarlal J, Nhampossa T, et al. Malaria in rural Mozambique. Part I: children attending the outpatient clinic. Malar J. 2008. https:\/\/doi.org\/10.1186\/1475-2875-7-36.","journal-title":"Malar J"},{"key":"935_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-37","author":"Q Bassat","year":"2008","unstructured":"Bassat Q, Guinovart C, Siga\u00faque B, Aide P, Sacarlal J, Nhampossa T, et al. Malaria in rural Mozambique. Part II: children admitted to hospital. Malar J. 2008. https:\/\/doi.org\/10.1186\/1475-2875-7-37.","journal-title":"Malar J"},{"issue":"4","key":"935_CR39","doi-asserted-by":"publisher","first-page":"626","DOI":"10.4269\/ajtmh.2011.11-0223","volume":"85","author":"Q Bassat","year":"2011","unstructured":"Bassat Q, Machevo S, O\u2019Callaghan-Gordo C, Siga\u00faque B, Morais L, D\u00edez-Padrisa N, et al. Distinguishing malaria from severe pneumonia among hospitalized children who fulfilled integrated management of childhood illness criteria for both diseases: a hospital-based study in Mozambique. Am J Trop Med Hyg. 2011;85(4):626\u201334.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"935_CR40","first-page":"48","volume":"31","author":"JU Ojukwu","year":"2004","unstructured":"Ojukwu JU, Ezeonu CT, Ogbu CN. Severe malaria in neonates masquerading as septicaemia. Niger J Paediatr. 2004;31(2):48\u201355.","journal-title":"Niger J Paediatr"},{"key":"935_CR41","doi-asserted-by":"crossref","unstructured":"Severe malaria. Trop Med Int Health. 2014;19(Suppl 1):7\u2013131.","DOI":"10.1111\/tmi.12313_2"},{"key":"935_CR42","doi-asserted-by":"publisher","unstructured":"Ameade EPK, Tee CG, Dakurah HC, Opata HM. Uncomplicated malaria in children under 6 months or less than 5 kg; how prescribers in Ghana manage it in the absence of a national policy. Int J Trop Dis. 2018. https:\/\/doi.org\/10.23937\/ijtd-2017\/1710002.","DOI":"10.23937\/ijtd-2017\/1710002"},{"key":"935_CR43","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2012.073","author":"RF Schumacher","year":"2012","unstructured":"Schumacher RF, Spinelli E. Malaria in children. Mediterr J Hematol Infect Dis. 2012. https:\/\/doi.org\/10.4084\/MJHID.2012.073.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"935_CR44","first-page":"48","volume":"22","author":"KY Lim","year":"2020","unstructured":"Lim KY, Ang EL, Tan KK, Mustakim S, Pediatrik J, Tengku H, et al. Neonatal malaria presenting as neonatal sepsis: a case report. Malays J Paediatr Child Health. 2020;22:48\u201357.","journal-title":"Malays J Paediatr Child Health"},{"key":"935_CR45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27731","author":"M Majety","year":"2022","unstructured":"Majety M, Majety P, Kammili V. Let\u2019s not miss the treatable ones: two cases of neonatal sepsis due to malaria. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.27731.","journal-title":"Cureus"},{"issue":"4","key":"935_CR46","first-page":"409","volume":"65","author":"T Tuyisenge","year":"2019","unstructured":"Tuyisenge T, Henry MB, Cartledge PT. Global health journal club: the use of rapid diagnostic test (RDT) in the diagnosis of congenital malaria. J Trop Pediatr. 2019;65(4):409\u201315.","journal-title":"J Trop Pediatr"},{"key":"935_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7060179","author":"J Talapko","year":"2019","unstructured":"Talapko J, \u0160krlec I, Alebi\u0107 T, Juki\u0107 M, V\u010dev A. Malaria: the past and the present. Microorganisms. 2019. https:\/\/doi.org\/10.3390\/microorganisms7060179.","journal-title":"Microorganisms"},{"issue":"10","key":"935_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240814","volume":"15","author":"AK Botwe","year":"2020","unstructured":"Botwe AK, Owusu-Agyei S, Asghar M, Hammar U, Oppong FB, Gyaase S, et al. Profiles of Plasmodium falciparum infections detected by microscopy through the first year of life in Kintampo a high transmission area of Ghana. PLoS ONE. 2020;15(10):e0240814.","journal-title":"PLoS ONE"},{"issue":"10","key":"935_CR49","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/cid\/ciab245","volume":"73","author":"N Zehner","year":"2021","unstructured":"Zehner N, Adrama H, Kakuru A, Andra T, Kajubi R, Conrad M, et al. Age-related changes in malaria clinical phenotypes during infancy are modified by sickle cell trait. Clin Infect Dis. 2021;73(10):1887\u201395.","journal-title":"Clin Infect Dis"},{"key":"935_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2007.01.018","author":"C Menendez","year":"2007","unstructured":"Menendez C, Mayor A. Congenital malaria: the least known consequence of malaria in pregnancy. Semin Fetal Neonatal Med. 2007. https:\/\/doi.org\/10.1016\/j.siny.2007.01.018.","journal-title":"Semin Fetal Neonatal Med"},{"key":"935_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa139","author":"S Park","year":"2020","unstructured":"Park S, Nixon CE, Miller O, Choi NK, Kurtis JD, Friedman JF, et al. Impact of malaria in pregnancy on risk of malaria in young children: systematic review and meta-analyses. J Infect Dis. 2020. https:\/\/doi.org\/10.1093\/infdis\/jiaa139.","journal-title":"J Infect Dis"},{"key":"935_CR52","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025551","author":"M Fried","year":"2017","unstructured":"Fried M, Duffy PE. Malaria during pregnancy. Cold Spring Harb Perspect Med. 2017. https:\/\/doi.org\/10.1101\/cshperspect.a025551.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"935_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaa074","author":"KL McKinney","year":"2020","unstructured":"McKinney KL, Wu HM, Tan KR, Gutman JR. Malaria in the pregnant traveler. J Travel Med. 2020. https:\/\/doi.org\/10.1093\/jtm\/taaa074.","journal-title":"J Travel Med"},{"key":"935_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2017.1312667","author":"FE Eki-Udoko","year":"2017","unstructured":"Eki-Udoko FE, Sadoh AE, Ibadin MO, Omoigberale AI. Prevalence of congenital malaria in newborns of mothers co-infected with HIV and malaria in Benin city. Infect Dis. 2017. https:\/\/doi.org\/10.1080\/23744235.2017.1312667.","journal-title":"Infect Dis"},{"issue":"5","key":"935_CR55","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/infdis\/jiq049","volume":"203","author":"A Bardaj\u00ed","year":"2011","unstructured":"Bardaj\u00ed A, Sigauque B, Sanz S, Maixenchs M, Ordi J, Aponte JJ, et al. Impact of malaria at the end of pregnancy on infant mortality and morbidity. J Infect Dis. 2011;203(5):691\u20139.","journal-title":"J Infect Dis"},{"key":"935_CR56","unstructured":"Burkina Faso national guidelines. 2014. https:\/\/www.severemalaria.org\/sites\/default\/files\/content\/document\/burkina%20faso%20treatment%20guidelines.pdf. Accessed 4 Dec 2025."},{"key":"935_CR57","unstructured":"Guidelines for the management of malaria in Cameroun intended for health personnel. 2014. https:\/\/www.severemalaria.org\/sites\/default\/files\/content\/document\/cameroon%20GUIDE%20DE%20PEC%20FINAL%20ANGLAIS%20%282%29_0.pdf. Accessed 4 Dec 2025."},{"key":"935_CR58","unstructured":"Democratic Republic of the Congo national guidelines. 2017. https:\/\/www.severemalaria.org\/sites\/mmv-smo\/files\/content\/attachments\/2017-11-20\/DRC%20DIRECTIVES%20NATIONALE%20DE%20PEC%20DU%20PALUDISME%202017.pdf. Accessed 4 Dec 2025."},{"key":"935_CR59","unstructured":"Guidelines for case management of malaria in Ghana. 2020. https:\/\/ghs.gov.gh\/api\/media\/file\/GUIDELINES_FOR_CASE_MANAGEMENT_OF_MALARIA.pdf. Accessed 04 Dec 2025."},{"key":"935_CR60","unstructured":"National guidelines for the management of malaria cases in Mali. 2016. https:\/\/www.severemalaria.org\/sites\/default\/files\/content\/document\/Mali%20treatment%20guidelines_0_0.pdf. Accessed 4 Dec 2025."},{"key":"935_CR61","unstructured":"Mozambique treatment guidelines. 2017. https:\/\/www.scribd.com\/document\/669469359\/Moz-Ch-33-01-Guideline-2017-Prt-Normas-Tratamento-Malaria. Accessed 4 Dec 2025."},{"key":"935_CR62","unstructured":"US President\u2019s malaria initiative - Niger. 2023. https:\/\/mesamalaria.org\/wp-content\/uploads\/2025\/04\/NIGER-Malaria-Profile-PMI-FY-2024.pdf. Accessed 4 Dec 2025."},{"key":"935_CR63","unstructured":"Nigeria Centre for Disease Control and Prevention\u2013Malaria. 2016. https:\/\/ncdc.gov.ng\/diseases\/factsheet\/24.%20Accessed%2012%20June%202024#treatment. Accessed 4 Dec 2025."},{"key":"935_CR64","unstructured":"Uganda clinical guidelines. 2016. https:\/\/www.severemalaria.org\/sites\/default\/files\/content\/document\/Uganda%20clinical%20guidelines%202016%20%281%29.pdf. Accessed 28 Sep 2025."},{"key":"935_CR65","unstructured":"National guidelines for malaria diagnosis, treatment and preventive therapies. 2020. https:\/\/www.nmcp.go.tz\/storage\/app\/uploads\/public\/643\/90d\/29e\/64390d29ef4b0392189644.pdf. Accessed 4 Dec 2025."},{"key":"935_CR66","unstructured":"Sudan malaria diagnosis and treatment protocol. 2017. https:\/\/reliefweb.int\/report\/sudan\/sudan-malaria-diagnosis-and-treatment-protocol-2017. Accessed 4 Dec 2025."},{"key":"935_CR67","volume-title":"Pre-referral treatment with rectal artesunate of children with suspected severe malaria: a field guide","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Pre-referral treatment with rectal artesunate of children with suspected severe malaria: a field guide. Geneva: World Health Organization; 2023."},{"key":"935_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s41182-025-00828-z","author":"G Wounounou","year":"2025","unstructured":"Wounounou G, Tiono AB, Ogutu B, Manyando C, Sagara I, Schneitter S, et al. Pharmacokinetics, safety, and efficacy of a new formulation of artemether-lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in neonates and infants of less than 5 kg body weight: a multicentre, open-label, single-arm phase 2\/3 study (CALINA). Trop Med Health. 2025. https:\/\/doi.org\/10.1186\/s41182-025-00828-z.","journal-title":"Trop Med Health"},{"key":"935_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0682-7","author":"AB Tiono","year":"2015","unstructured":"Tiono AB, Tinto H, Alao MJ, Meremikwu M, Tshefu A, Ogutu B, et al. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem\u00ae). Malar J. 2015. https:\/\/doi.org\/10.1186\/s12936-015-0682-7.","journal-title":"Malar J"},{"key":"935_CR70","doi-asserted-by":"publisher","DOI":"10.1128\/aac.46.3.821-827.2002","author":"G Schmuck","year":"2002","unstructured":"Schmuck G, Roehrdanz E, Haynes RK, Kahl R. Neurotoxic mode of action of artemisinin. Antimicrob Agents Chemother. 2002. https:\/\/doi.org\/10.1128\/aac.46.3.821-827.2002.","journal-title":"Antimicrob Agents Chemother"},{"key":"935_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2006.06.001","author":"S Toovey","year":"2006","unstructured":"Toovey S. Are currently deployed artemisinins neurotoxic? Toxicol Lett. 2006. https:\/\/doi.org\/10.1016\/j.toxlet.2006.06.001.","journal-title":"Toxicol Lett"},{"key":"935_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2010.09.005","author":"Q Li","year":"2011","unstructured":"Li Q, Hickman M. Toxicokinetic and toxicodynamic (TK\/TD) evaluation to determine and predict the neurotoxicity of artemisinins. Toxicology. 2011. https:\/\/doi.org\/10.1016\/j.tox.2010.09.005.","journal-title":"Toxicology"},{"key":"935_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.16132","author":"CG Banda","year":"2025","unstructured":"Banda CG, Tarning J, Barnes KI. Use of population pharmacokinetic-pharmacodynamic modelling to inform antimalarial dose optimization in infants. Br J Clin Pharmacol. 2025. https:\/\/doi.org\/10.1111\/bcp.16132.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"935_CR74","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4269\/ajtmh.1996.54.237","volume":"54","author":"MB van Hensbroek","year":"1996","unstructured":"van Hensbroek MB, Kwiatkowski D, van den Berg B, Hoek FJ, van Boxtel CJ, Kager PA. Quinine pharmacokinetics in young children with severe malaria. Am J Trop Med Hyg. 1996;54(3):237\u201342.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"935_CR75","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157\u201367.","journal-title":"N Engl J Med"},{"key":"935_CR76","unstructured":"World Health Organization. Seasonal malaria chemoprevention with sulfadoxine\u2013pyrimethamine plus amodiaquine in children: a field guide; 2023. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/1e4c18a4-bb5a-409d-bdc4-5f492f212853\/content. Accessed 4 Dec 2025."},{"key":"935_CR77","first-page":"9960006","volume":"2021","author":"D Kajoba","year":"2021","unstructured":"Kajoba D, Ivan Egesa W, Jean Petit H, Omar Matan M, Laker G, Mugowa Waibi W, et al. Congenital malaria in a 2-day-old neonate: a case report and literature review. Case Rep Infect Dis. 2021;2021:9960006.","journal-title":"Case Rep Infect Dis"},{"key":"935_CR78","unstructured":"World Health Organization. World malaria report 2019. Geneva: World Health Organization; 2019. https:\/\/www.who.int\/publications\/i\/item\/9789241565721. Accessed 3 Jun 2024."},{"key":"935_CR79","unstructured":"UNICEF. Fighting malaria with long-lasting insecticidal nets (LLINs) | UNICEF Supply Division. 2022. https:\/\/www.unicef.org\/supply\/stories\/fighting-malaria-long-lasting-insecticidal-nets-llins. Accessed 3 Jun 2024."},{"key":"935_CR80","doi-asserted-by":"crossref","unstructured":"RTS, S Clinical Trials Partnership; Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, et al. First results of phase 3 trial of RTS,S\/AS01 malaria vaccine in African children. N Engl J Med. 2011;365:1863-75.","DOI":"10.1056\/NEJMoa1102287"},{"key":"935_CR81","doi-asserted-by":"crossref","unstructured":"RTS,S Clinical Trials Partnership; Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, et al. A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants. N Engl J Med. 2012;367(24):2284-95.","DOI":"10.1056\/NEJMoa1208394"},{"issue":"12","key":"935_CR82","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","volume":"22","author":"MS Datoo","year":"2022","unstructured":"Datoo MS, Natama HM, Som\u00e9 A, Bellamy D, Traor\u00e9 O, Rouamba T, et al. Efficacy and immunogenicity of R21\/Matrix-M vaccine against clinical malaria after 2 years\u2019 follow-up in children in Burkina Faso: a phase 1\/2b randomised controlled trial. Lancet Infect Dis. 2022;22(12):1728\u201336.","journal-title":"Lancet Infect Dis"},{"key":"935_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60721-8","author":"RTS,S Clinical Trials Partnership","year":"2015","unstructured":"RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015. https:\/\/doi.org\/10.1016\/S0140-6736(15)60721-8. (Erratum in: Lancet. 2015. 10.1016\/S0140-6736(15)60643-2.).","journal-title":"Lancet"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-026-00935-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-026-00935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-026-00935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T02:20:24Z","timestamp":1779416424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41182-026-00935-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["935"],"URL":"https:\/\/doi.org\/10.1186\/s41182-026-00935-5","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JD, QB and UDA declare no competing interests. HA receives payment or honoraria from Yale University and ETH Zurich and reports as a startup advisor to Nemosia AG and was an employee of Novartis at the time of the study. SP is an employee of Novartis. CW, CB, NO are employees of Novartis and own Novartis stocks.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}